The coronavirus has transformed life for billions of people in just a few short weeks. Since the first U.S. COVID-19 case was reported on January 21st, the number of known cases has grown significantly nationwide, reaching pandemic status and straining healthcare systems. More information is becoming available day by day as the situation evolves.

COVID-19 has infected millions of people and has taken so many lives around the globe. Unwilling to stand by and do nothing as the economy and our communities struggle, companies all around the U.S. are looking for ways to help fight the virus, ensure business continuity, and keep generating revenue.

Will premiums increase? Are terms and conditions changing? What lines of business have limited markets? Which lines of business have excess capacity? Here’s what clients can expect in the marketplace for 2020 in a quick and easy to read reference guide.

Healthcare organizations, already under financial pressure from the changing reimbursement system, now face a hardening D&O liability insurance marketplace. In this article, CRC offers insights on how retail agents can help their insureds navigate the difficult environment.

The health care sector is caught in the crosscurrents of the opioid crisis. Easing pain is an integral goal of medical treatment, and when it comes to severe pain, prescription opioids have proven very effective. Opioid pain relievers, however, can be highly addictive and are often abused.